Quarterly report · Q3

Period2023-01-01 → 2023-09-30
Filed2023-11-10
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 37
MetricValuePeriodScopeSource row
Revenue¥8.0bn2023-01-01 → 2023-09-30StandaloneNet sales
Revenue¥17.6bn2022-01-01 → 2022-12-31StandaloneNet sales (5-year summary)
Revenue¥13.3bn2022-01-01 → 2022-09-30StandaloneNet sales
Operating income¥3.8bn2023-01-01 → 2023-09-30StandaloneOperating income
Operating income¥8.7bn2022-01-01 → 2022-09-30StandaloneOperating income
Ordinary income¥4.0bn2023-01-01 → 2023-09-30StandaloneOrdinary income
Ordinary income¥11.1bn2022-01-01 → 2022-12-31StandaloneOrdinary income loss (5-year summary)
Ordinary income¥8.8bn2022-01-01 → 2022-09-30StandaloneOrdinary income
Profit before tax¥4.0bn2023-01-01 → 2023-09-30StandaloneIncome before income taxes
Profit before tax¥8.8bn2022-01-01 → 2022-09-30StandaloneIncome before income taxes
Net income¥2.8bn2023-01-01 → 2023-09-30StandaloneProfit loss
Net income¥7.8bn2022-01-01 → 2022-12-31StandaloneNet income loss (5-year summary)
Net income¥6.1bn2022-01-01 → 2022-09-30StandaloneProfit loss
Total assets¥17.7bnat 2023-09-30StandaloneAssets
Total assets¥19.1bnat 2022-12-31StandaloneAssets
Total assets¥16.5bnat 2022-09-30StandaloneTotal assets (5-year summary)
Total liabilities¥3.0bnat 2023-09-30StandaloneLiabilities
Total liabilities¥4.8bnat 2022-12-31StandaloneLiabilities
Net assets / equity¥14.7bnat 2023-09-30StandaloneNet assets
Net assets / equity¥14.3bnat 2022-12-31StandaloneNet assets
Net assets / equity¥12.6bnat 2022-09-30StandaloneNet assets (5-year summary)
Cash and deposits¥8.9bnat 2023-09-30StandaloneCash and deposits
Cash and deposits¥8.7bnat 2022-12-31StandaloneCash and deposits
EPS (basic)¥296.882023-01-01 → 2023-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥143.432023-07-01 → 2023-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥822.942022-01-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥643.872022-01-01 → 2022-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥307.52022-07-01 → 2022-09-30dStandaloneBasic earnings loss per share (5-year summary)
Dividend per share¥602023-01-01 → 2023-09-30StandaloneDividend paid per share (5-year summary)
Dividend per share¥2502022-01-01 → 2022-12-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥602022-01-01 → 2022-09-30StandaloneDividend paid per share (5-year summary)
Equity ratio83.1%at 2023-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio74.8%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio76.3%at 2022-09-30StandaloneEquity to asset ratio (5-year summary)
Shares issued9,525,000at 2023-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued9,525,000at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued9,525,000at 2022-09-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 262
ItemContextValueUnit
Notes regarding dividend (text)Prior1YTDDuration_NonConsolidatedMemberText · Plus
Notes when there is significant changes in amounts of equity (text)Prior1YTDDuration_NonConsolidatedMemberText · Plus
Notes regarding dividend (text)CurrentYTDDuration_NonConsolidatedMemberText · Plus
Notes equity in earnings losses of affiliates if equity method is applied quarterly financial statements (text)CurrentYTDDurationText · Plus
Notes segment information etc quarterly financial statements (text)CurrentYTDDurationText · Plus
Description of fact that companys business comprises single segmentPrior1YTDDuration_NonConsolidatedMember
Original text (Japanese)当社は、体外診断用医薬品事業の単一セグメントであるため、記載を省略しております。
Description of fact that companys business comprises single segmentCurrentYTDDuration_NonConsolidatedMember
Original text (Japanese)当社は、体外診断用医薬品事業の単一セグメントであるため、記載を省略しております。
Notes revenue recognition quarterly financial statements (text)CurrentYTDDurationText · Plus
Notes per share information quarterly financial statements (text)CurrentYTDDurationText · Plus
Notes significant events after reporting period quarterly financial statements (text)CurrentYTDDurationText · Plus
Other information financial statements etc (text)CurrentYTDDurationText · Plus
Information about company which provides guarantee to reporting company (text)FilingDateInstantText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 10 of 10 passed
balance sheet identitynon_consolidated 2022-12-31pass
balance sheet identitynon_consolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2023-09-30pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-09-30pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-09-30pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass
statement vs summary · total assetsnon_consolidated 2023-09-30pass